AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
$19.18 0.46 (2.4573%)
Analysed AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) News Sources
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty
02-06-2026
yahoo.com
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
04-06-2026
marketbeat.com
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts
09-06-2026
yahoo.com
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
10-06-2026
marketbeat.com
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
12-06-2026
yahoo.com
New Strong Sell Stocks for June 23rd
23-06-2026
yahoo.com
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
29-06-2026
yahoo.com
BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last?
10-07-2026
yahoo.com
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
10-07-2026
yahoo.com
3 Stocks Under $50 We Keep Off Our Radar
22-07-2026
yahoo.com
What is the current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is $19.18.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is $0.46.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is 2.4573%.
What is the most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is .
SEC-8K** Filing Available For AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.